Administration of CoQ10 delayed tumor growth by four weeks vs vehicle (Fig. 1A), which was reflected in a 50% reduction in the proliferation marker Ki-67 (Fig. 1B) and a dramatic reduction of hypoxia—which was almost absent in CoQ10-treated tumors (Fig. 1C, Supp. This evidence concerns the gene MKI67 and neoplasm.